Meridian’s SARS-CoV-2 Molecular Assay Gets FDA Re-Authorization
Meridian Bioscience received re-authorization from the FDA of its Emergency Use Authorization (EUA) for a SARS-COV-2 molecular assay.
Read MorePosted by Andy Lundin | Aug 1, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Meridian Bioscience received re-authorization from the FDA of its Emergency Use Authorization (EUA) for a SARS-COV-2 molecular assay.
Read MorePosted by Andy Lundin | Jul 29, 2022 | Covid 19, Diagnostic Technologies |
Ubiquitome revealed the Liberty16 Pro COVID testing tool at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.
Read MorePosted by Andy Lundin | Jul 29, 2022 | Covid 19 |
Rheonix Laboratories has been permitted by New York to provide low-cost COVID PCR testing and results across the state.
Read MorePosted by Andy Lundin | Jul 29, 2022 | Emerging & Zoonotic Diseases, Immunoassay Reagents & test Kits |
BD and CerTest Biotec announced their newly developed molecular PCR test for the monkeypox virus is commercially available outside the U.S.
Read MorePosted by Andy Lundin | Jul 28, 2022 | Covid 19 |
SummerBio will transition to standby-mode at the end of the August due to a dramatic reduction in the demand for COVID lab-based PCR testing.
Read More